Patrick Rossignol
Patrick Rossignol, MD is an expert in Cardiology at Centre Hospitalier Universitaire de Nancy (France). As of October 2026, ScienceLeadR ranks Patrick Rossignol in the top 1% of experts worldwide for Hyperkalemia, Heart Failure and Renal Insufficiency. Patrick Rossignol has authored 780 publications, the most recent in 2026, and is an investigator in 51 clinical trials, 2 of them ongoing. SLR score: 3,063 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Nephrology - Nutrition
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2001 - 2026
Number : 780
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury. PMID 42873070 — continuous renal replacement therapy, mortality, kidney, respect, critical illness, therapeutics, renal replacement therapy, acute kidney injury | N Engl J Med Top journal | 2026 | 1 |
| Redefining Cardiometabolic Disease: Expert Consensus on the CardioVascular-Kidney-Liver-Metabolic (CVKLM) Multiorgan Staging. PMID 42945405 — liver diseases, diabetes mellitus, heart, cardiovascular diseases, kidney, liver, obesity, therapeutics | Eur J Prev Cardiol | 2026 | 0 |
| Intrarenal Determinants of GFR Decline During Loop Diuretic Therapy. PMID 42670726 — glomerular filtration rate, vasoconstriction, torsemide, renin, extracellular fluid, diuretics, therapeutics, furosemide, hemodynamics | Hypertension | 2026 | 0 |
| Evaluation and Management of Anemia in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2026 Clinical Practice Guideline. PMID 42735412 — kidney diseases, anemia, internal medicine, kidney, therapeutics | Ann Intern Med | 2026 | 1 |
| Urinary proteomic signature of exercise intolerance in patients at risk of heart failure: evidence from the HOMAGE trial. PMID 42531722 — exercise, muscles, heart failure, biomedical research, heart, stress, physiological, collagen, oxidative stress, signs and symptoms, walk test | EBioMedicine | 2026 | 0 |
Clinical Studies 51
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 13
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Potassium Canrenoate in Brain dead Organ Donors Randomized Controlled Clinical Trial NCT04714710 — operating rooms, pharmaceutical preparations, brain, kidney, receptors, mineralocorticoid, brain death, reperfusion injury, diagnosis, transplants, mineralocorticoids, hemodynamics, canrenoic acid | Phase 2 | Active not recruiting | 2021 |
| Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity mortality Endpoint in Patients With Cardiogenic Shock NCT04020263 — mortality, absenteeism, shock, cardiogenic, simendan, heart failure, heart, solutions, signs and symptoms, cardiac output, dobutamine, body weight, morbidity | Phase 3 | Recruiting | 2023 |
LeadR Networks
Main global connection map